Incyte Corporation (LON:0J9P)
67.45
-1.16 (-1.70%)
At close: Jul 7, 2025
Incyte Revenue
Incyte had revenue of $1.05B USD in the quarter ending March 31, 2025, with 19.53% growth. This brings the company's revenue in the last twelve months to $4.41B, up 17.13% year-over-year. In the year 2024, Incyte had annual revenue of $4.24B with 14.76% growth.
Revenue (ttm)
$4.41B
Revenue Growth
+17.13%
P/S Ratio
2.83
Revenue / Employee
$1.69M
Employees
2,617
Market Cap
9.66B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.24B | 545.57M | 14.76% |
Dec 31, 2023 | 3.70B | 301.01M | 8.87% |
Dec 31, 2022 | 3.39B | 408.37M | 13.67% |
Dec 31, 2021 | 2.99B | 319.57M | 11.98% |
Dec 31, 2020 | 2.67B | 507.94M | 23.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Incyte News
- 6 days ago - Incyte: New CEO Brings A New Possible Outcome - Seeking Alpha
- 6 days ago - Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Notable Insider Move: William Meury Takes Part In Options Exercise At Incyte, Resulting In $0 - Benzinga
- 11 days ago - Incyte Stock Gets Relative Strength Rating Lift - Investor's Business Daily
- 12 days ago - Incyte Stock Rises as Pharmaceutical Firm Appoints New CEO - Investopedia
- 13 days ago - Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes - Investor's Business Daily
- 13 days ago - Incyte taps Bill Meury as CEO - Seeking Alpha
- 13 days ago - Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire - Business Wire